期刊文献+

重组人Tum-5融合蛋白的克隆、表达、纯化及鉴定 被引量:1

Identification, purification, expression and cloning of fusion protein rhTum-5
在线阅读 下载PDF
导出
摘要 目的:构建人肿瘤抑素(tumstatin)活性片段Tum5的融合重组表达载体并对其进行诱导表达和蛋白纯化以获得大量重组融合蛋白.方法:人工合成Tum5基因,进行测序分析,将该基因克隆入原核表达载体pQE30中,转化感受态细胞DH5α,经IPTG诱导表达重组融合蛋白,对表达产物进行TricineSDSPAGE电泳分析和WesternBlot检测分析.结果构建了重组融合表达质粒pQE30Tum5,表达的蛋白经TricineSDSPAGE电泳分析,在约Mr10×103处出现了一条新生的蛋白条带,经灰度扫描检测,表达量约占菌体总蛋白的40%,纯化后的蛋白灰度扫描检测,纯度为95%.结论:成功地构建了人Tum5基因的原核表达载体,并纯化了该基因的原核表达产物. AIM: To construct the recombinant expression vector of Tum-5 and to purify and identify the fusion protein rhTum-5. METHODS: A 264 bp of human Tum-5 gene fragment was synthesized and cloned into pQE-30 vector, an E.coli expression vector. The plasmid was transformed into E.coli DH5α and induced to express fusion protein rhTum-5 with IPTG. The expression of Tum-5 was detected by Tricine-SDS-PAGE and Western blot. RESULTS: A novel protein with expected molecular mass was expressed upon induction with IPTG. The expressed product accounted for about 40% of total bacterial proteins and showed good reactivity to anti-His tag antibody. CONCLUSION: Our successful cloning and expression of human Tum-5 gene and purification of rhTum-5 protein lay a basis for further study on the application of this protein to anti-angiogenesis in vitro and in vivo.
出处 《第四军医大学学报》 北大核心 2005年第14期1279-1281,共3页 Journal of the Fourth Military Medical University
关键词 TUMSTATIN Tum-5 重组融合蛋白质类/分离和提纯 pQE载体 tumstatin Tum-5 recombinant fusion proteins/isolation & purification pQE vector
  • 相关文献

参考文献5

  • 1Maeshima Y, Colorado PC, Torre, A, et al. Distinct antitumor properties of a type Ⅳ collagen domain derived from basement membrane [J]. J Biol Chem, 2000; 275(28) :21340-21348.
  • 2Maeshima Y, Manfredi M, Reimer C, et al. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin [J]. JBiol Chem, 2001;276(18): 15240-15248.
  • 3石继红,赵永同,王俊楼,韩苇,颜真,张英起.SDS-聚丙烯酰胺凝胶电泳分析小分子多肽[J].第四军医大学学报,2000,21(6):761-763. 被引量:71
  • 4Hamano Y, Zeisberg M. Physiological levels of tumstatin, a fragment of collagen Ⅳα3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin [ J ]. Cancer Cell, 2003;3(6) :589 -601.
  • 5Folkman J. Tumor angiogenesis: Therapeutic implications [ J ]. N Engl J Med, 1971 ;285(21 ) :1182 - 1186.

二级参考文献2

共引文献70

同被引文献4

  • 1J.萨姆布鲁克,E.F.弗里奇,T.曼尼阿蒂斯.分子克隆实验指南[M].北京:科学出版社.1999.845.
  • 2Hellmark T, Burkhardt H, Wieslander J. Goodpasture disease Characterization of a single conformational epitope as the target of pathogenic autoantibodies [J]. Biol Chem. 1999, 274(36): 25862-25569.
  • 3Jieru Meng, Nan Ma, Zhen Yan et al. NGR Enhanced the Anti-Angiogenic Activity of turn-5 [J]. Biochem. 140, 1-6 (2006) doi: 10.1093/ jb/mvj 152.
  • 4俞俊棠,唐孝宣.生物工艺学[M].上海:华东理工大学出版社,1994.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部